Literature DB >> 21757586

Progression of age-related geographic atrophy: role of the fellow eye.

Monika Fleckenstein1, Steffen Schmitz-Valckenberg, Christine Adrion, Sivatharisini Visvalingam, Arno P Göbel, Andreas Mössner, Claudia N von Strachwitz, Friederike Mackensen, Daniel Pauleikhoff, Sebastian Wolf, Ulrich Mansmann, Frank G Holz.   

Abstract

PURPOSE. To evaluate the role of fellow eye status in determining progression of geographic atrophy (GA) in patients with age-related macular degeneration (AMD). METHODS. A total of 300 eyes with GA of 193 patients from the prospective, longitudinal, natural history FAM Study were classified into three groups according to the AMD manifestation in the fellow eye at baseline examination: (1) bilateral GA, (2) early/intermediate AMD, and (3) exudative AMD. GA areas were quantified based on fundus autofluorescence images using a semiautomated image-processing method, and progression rates (PR) were estimated using two-level, linear, mixed-effects models. RESULTS. Crude GA-PR in the bilateral GA group (mean, 1.64 mm(2)/y; 95% CI, 1.478-1.803) was significantly higher than in the fellow eye early/intermediate group (0.74 mm(2)/y, 0.146-1.342). Although there was a significant difference in baseline GA size (P = 0.0013, t-test), and there was a significant increase in GA-PR by 0.11 mm(2)/y (0.05-0.17) per 1 disc area (DA; 2.54 mm(2)), an additional mean change of -0.79 (-1.43 to -0.15) was given to the PR beside the effect of baseline GA size. However, this difference was only significant when GA size was ≥1 DA at baseline with a GA-PR of 1.70 mm(2)/y (1.54-1.85) in the bilateral and 0.95 mm(2)/y (0.37-1.54) in the early/intermediate group. There was no significant difference in PR compared with that in the fellow eye exudative group. CONCLUSIONS. The results indicate that the AMD manifestation of the fellow eye at baseline serves as an indicator for disease progression in eyes with GA ≥ 1 DA. Predictive characteristics not only contribute to the understanding of pathophysiological mechanisms, but also are useful for the design of future interventional trials in GA patients.

Entities:  

Mesh:

Year:  2011        PMID: 21757586     DOI: 10.1167/iovs.11-7298

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.

Authors:  Marc Biarnés; Jordi Monés; Fabio Trindade; Jordi Alonso; Luis Arias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-28       Impact factor: 3.117

2.  Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular Degeneration.

Authors:  Alisa T Thavikulwat; Naima Jacobs-El; Jane S Kim; Elvira Agrón; Jesia Hasan; Catherine B Meyerle; David Valent; Catherine A Cukras; Henry E Wiley; Wai T Wong; Emily Y Chew
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

Review 3.  Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Frank G Holz; Julia S Steinberg; Arno Göbel; Monika Fleckenstein; Steffen Schmitz-Valckenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-19       Impact factor: 3.117

Review 4.  GEOGRAPHIC ATROPHY: Semantic Considerations and Literature Review.

Authors:  Steffen Schmitz-Valckenberg; Srinivas Sadda; Giovanni Staurenghi; Emily Y Chew; Monika Fleckenstein; Frank G Holz
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

5.  Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population.

Authors:  B Diniz; D C Rodger; V R Chavali; T MacKay; S Y Lee; D Stambolian; S V R Sadda
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

Review 6.  Perspectives from clinical trials: is geographic atrophy one disease?

Authors:  Sobha Sivaprasad; Shruti Chandra; Jeha Kwon; Noorulain Khalid; Victor Chong
Journal:  Eye (Lond)       Date:  2022-05-31       Impact factor: 3.775

7.  Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.

Authors:  Felix Grassmann; Monika Fleckenstein; Emily Y Chew; Tobias Strunz; Steffen Schmitz-Valckenberg; Arno P Göbel; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frank G Holz; Bernhard H F Weber
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 8.  THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.

Authors:  David S Boyer; Ursula Schmidt-Erfurth; Menno van Lookeren Campagne; Erin C Henry; Christopher Brittain
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

9.  Genetic Association Analysis of Drusen Progression.

Authors:  Joshua D Hoffman; Mark J J P van Grinsven; Chun Li; Milam Brantley; Josephine McGrath; Anita Agarwal; William K Scott; Stephen G Schwartz; Jaclyn Kovach; Margaret Pericak-Vance; Clara I Sanchez; Jonathan L Haines
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.